Newsroom hero banner
split-image
first

Get the latest ZS news and press releases

We apply our knowledge, capabilities and innovation-oriented approach to a broad range of industries and client issues.
true
white
ABOUT ZS
false
Download the report
/content/dam/global/master/pdfs/esg-report-2024.pdf
primary
Second Button CTA Text
#
secondary
text-first
true
LIFE SCIENCES
grey
ZS to bring ZAIDYN® intelligence to Agentforce Life Sciences
h3
Oct. 22, 2025 | Press release
true
/content/zs/en/about/newsroom/zs-press-salesforce-zaidyn-crm
Read more
Read more
primary
arrow-right
image
Join our team
asset
/content/dam/demo-zs/test-assets/video-2160p.mp4
Sample Video Title
default

In the news

left
white
Eyebrow Text
Button CTA Text
#
primary
default
/content/zs/en/about/newsroom
https://www.pharmexec.com/view/the-pulse-of-pharma-change-in-2026
The pulse of pharma change in 2026
2026-02-20T00:00:00.000Z
zs:content-type/podcast
https://www.businesswire.com/news/home/20260115349983/en/Healthcare-Sector-Calls-for-Unified-Federal-Framework-to-Unlock-AIs-Full-Potential-for-Patients
Healthcare sector calls for united Federal framework to unlock AI’s full potential
2026-01-15T00:00:00.000Z
zs:content-type/press-release
https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-ai-drug-rd-development/809144/
What’s next for AI and drug R&D
2026-01-09T00:00:00.000Z
zs:content-type/press-release
https://www.pharmavoice.com/news/fda-drug-approval-takeda-novo-merck-lilly-2026/808924/
5 FDA drug approvals to watch in 2026
2026-01-07T00:00:00.000Z
zs:content-type/article
https://www.pharmavoice.com/news/dtc-advertisement-pharma-rfk-fda/760663/
With DTC ads under fire, pharma companies need to pivot
2025-09-22T00:00:00.000Z
zs:content-type/article
https://www.hotelmanagement.net/data-trends/report-how-hoteliers-can-boost-profits-noncore-assets
Report: How hoteliers can boost profits with noncore assets
2025-09-16T00:00:00.000Z
zs:content-type/article
https://diginomica.com/wall-street-smells-blood-water-whats-ailing-consulting-and-research
As Wall Street smells blood in the water, what's ailing consulting and research?
2025-08-19T00:00:00.000Z
zs:content-type/article
Your patient's smartwatch could be a legal timebomb: are you liable?
2025-07-30T00:00:00.000Z
zs:content-type/article
https://medcitynews.com/2025/07/pharmaceutical-tariffs-supply-chain-drug-manufacturing-trade-wto-trump-cell-therapy-nkarta/
The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains
2025-07-23T00:00:00.000Z
zs:content-type/article
https://www.pharmavoice.com/news/covid-vax-restrictions-market-uptake-hhs-rfk-moderna/750211/
COVID vax restrictions may not hamper uptake — but the market is still under pressure
2025-06-10T00:00:00.000Z
zs:content-type/article
https://www.pharmexec.com/view/the-three-pillars-of-pharma-s-new-commercial-model
The Three Pillars of Pharma’s New Commercial Model
2025-05-12T00:00:00.000Z
zs:content-type/article
https://www.techtarget.com/healthtechanalytics/feature/The-cost-of-AI-in-healthcare-explained-Is-it-worth-it
The cost of AI in healthcare explained. Is it worth it?
2025-05-01T00:00:00.000Z
zs:content-type/article
default

Media contact

For more information, please contact our media relations team.

Contact
Maryam Ayromlou
Ruder Finn
zs-RFMedia@ruderfinn.com
+1 703 474 5685

left
true
grey
MEDIA RESOURCES
Button CTA Text
#
primary
default
image
ZS’s recognition and rankings
h3
Leading, independent industry experts have recognized ZS’s talent and culture.
Learn more
/content/zs/en/about/awards-and-recognition
Fact sheet
h3
Get our corporate overview, executive bios and other important information about ZS.
Learn more
/content/dam/global/master/pdfs/factsheet-jan-2026.pdf